Boeing shares fell 1.2% in the premarket.Intellia Therapeutics (NTLA)– Intellia shares surged 55.4% in the premarket after the Massachusetts-based business and partner Regeneron (REGN) revealed positive results in a stage 1 study of a gene-editing treatment for an illness called transthyretin amyloidosis. Two other business included with the very same gene-editing innovation likewise rallied in premarket trading, with CRISPR Therapeutics (CRSP) skyrocketing 13.5% and Editas Medicine (EDIT) leaping 17.1%. The public display screen of assistance comes from Broadcom (AVGO), Marvell (MRVL) and MediaTek.MetLife (MET)– MetLife got an offer from Netherlands-based insurance provider NN Group for some of MetLifes European companies, though NN did not say which services were included or how much it had offered.MicroStrategy (MSTR)– The organization analytics companys stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin.